Dzuveo is an opioid pain medicine used to treat moderate to severe pain in adults. It is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ (called Sufenta Forte) containing the same active substance. The difference between the products is that Dzuveo is available as sublingual tablets (tablets to be dissolved under the tongue) while the reference medicine is a solution for injection. Dzuveo contains the active substance sufentanil.
Therapeutic Indication
### Therapeutic indication Dzuveo is indicated for the management of acute moderate to severe pain in adult patients.
Therapeutic Area (MeSH)
N/AATC Code
N01AH03
ATC Item
sufentanil
Pharmacotherapeutic Group
Anesthetics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| sufentanil citrate | N/A | 舒芬太尼 |
EMA Name
Dzuveo
Medicine Name
Dzuveo
Aliases
N/ANo risk management plan link.
